IRIS
CAROTENUTO, ALFONSO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 7.235
NA - Nord America 6.984
EU - Europa 5.174
SA - Sud America 833
Continente sconosciuto - Info sul continente non disponibili 355
AF - Africa 190
OC - Oceania 7
Totale 20.778
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.680
SG - Singapore 3.187
RU - Federazione Russa 2.316
CN - Cina 1.420
VN - Vietnam 1.282
IT - Italia 1.028
BR - Brasile 663
HK - Hong Kong 549
DE - Germania 292
FR - Francia 274
IE - Irlanda 232
FI - Finlandia 228
NL - Olanda 198
UA - Ucraina 169
CA - Canada 161
GB - Regno Unito 155
IN - India 138
JP - Giappone 134
BD - Bangladesh 109
SE - Svezia 96
MX - Messico 65
AR - Argentina 63
CI - Costa d'Avorio 56
KR - Corea 51
IQ - Iraq 49
PH - Filippine 45
TH - Thailandia 40
ZA - Sudafrica 40
PL - Polonia 39
ES - Italia 38
TR - Turchia 38
ID - Indonesia 31
TW - Taiwan 25
EC - Ecuador 22
AT - Austria 20
BE - Belgio 20
CO - Colombia 20
JM - Giamaica 19
PK - Pakistan 19
VE - Venezuela 16
IL - Israele 14
MA - Marocco 14
PY - Paraguay 14
CL - Cile 12
CR - Costa Rica 12
EG - Egitto 12
LT - Lituania 11
MY - Malesia 11
NP - Nepal 11
JO - Giordania 10
PE - Perù 10
UZ - Uzbekistan 10
BG - Bulgaria 9
KE - Kenya 9
SA - Arabia Saudita 9
TT - Trinidad e Tobago 9
UY - Uruguay 9
DZ - Algeria 8
IR - Iran 8
AZ - Azerbaigian 7
DO - Repubblica Dominicana 7
KZ - Kazakistan 7
SN - Senegal 7
AE - Emirati Arabi Uniti 6
GT - Guatemala 6
HN - Honduras 6
TN - Tunisia 6
ET - Etiopia 5
GR - Grecia 5
NG - Nigeria 5
OM - Oman 5
RO - Romania 5
CH - Svizzera 4
MD - Moldavia 4
PS - Palestinian Territory 4
AU - Australia 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BH - Bahrain 3
BO - Bolivia 3
EU - Europa 3
GA - Gabon 3
LV - Lettonia 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PA - Panama 3
PR - Porto Rico 3
PT - Portogallo 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
BS - Bahamas 2
BZ - Belize 2
CD - Congo 2
CZ - Repubblica Ceca 2
DJ - Gibuti 2
HR - Croazia 2
LU - Lussemburgo 2
MG - Madagascar 2
MU - Mauritius 2
Totale 20.381
Salva come PNG Salva come JPEG
Città #
Singapore 1.436
San Jose 1.049
Chandler 585
Moscow 564
Hong Kong 526
Ashburn 518
Beijing 436
Ho Chi Minh City 360
Santa Clara 328
Hanoi 289
Naples 273
Dallas 199
Amsterdam 186
Hefei 183
Los Angeles 179
Lauterbourg 176
Millbury 174
Princeton 169
Jacksonville 166
Council Bluffs 149
Boston 143
The Dalles 141
Nanjing 132
Napoli 115
Tokyo 107
New York 94
Buffalo 87
São Paulo 81
Munich 74
Ottawa 71
Wilmington 66
Da Nang 63
Des Moines 63
Redondo Beach 58
Woodbridge 56
Brooklyn 53
Haiphong 47
Ann Arbor 46
Houston 44
Seattle 44
Nanchang 38
Denver 37
Orem 37
Turku 37
Warsaw 37
Milan 35
Rome 35
Chicago 34
Frankfurt am Main 34
Phoenix 34
Seoul 33
Mexico City 32
Biên Hòa 30
Shenyang 30
Montreal 29
Toronto 29
Atlanta 27
Helsinki 27
Tianjin 25
Hebei 24
Nuremberg 24
Poplar 24
Rio de Janeiro 24
Bangkok 23
Chennai 23
North Bergen 23
Falls Church 21
Stockholm 21
Falkenstein 20
San Francisco 20
Washington 20
Baghdad 19
London 19
Augusta 18
Bologna 18
Changsha 18
Columbus 18
Jiaxing 18
Charlotte 17
Boardman 16
Kronberg 16
Hải Dương 15
Ninh Bình 15
Norwalk 15
Dong Ket 14
Florence 14
Hangzhou 14
Johannesburg 14
Lawrence 14
Ankara 13
Dublin 13
Düsseldorf 13
Guangzhou 13
Kingston 13
Manchester 13
Memphis 13
Belo Horizonte 12
Pune 12
Brussels 11
Can Tho 11
Totale 10.846
Salva come PNG Salva come JPEG
Nome #
" Molecular Modelingof the Urotensin-II receptor Complex" 244
Functional Selectivity Revealed by N-Methylation Scanning of Human Urotensin II and Related Peptides 240
Urokinase receptor derived peptides as potent inhibitors of the formyl peptide receptor type 1-triggered cell migration 204
Screening Platform toward New Anti-HIV Aptamers Set on Molecular Docking and Fluorescence Quenching Techniques 198
Antimicrobial peptide Temporin-L complexed with anionic cyclodextrins results in a potent and safe agent against sessile bacteria 189
Alanine scanning analysis and structure-function relationships of the frog-skin antimicrobial peptide temporin-1Ta 179
Discovery of 2,3-Diaminoindole Derivatives as a Novel Class of NOD Antagonists 175
A nutraceutical formulation based on Annurca apple polyphenolic extract is effective on intestinal cholesterol absorption: A randomised, placebo-controlled, crossover study 173
Discovery of Novel Potent and Selective Agonists at the Melanocortin-3 Receptor 172
Exploring the N-Terminal Region of C-X-C Motif Chemokine 12 (CXCL12): Identification of Plasma-Stable Cyclic Peptides As Novel, Potent C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonists 167
Unraveling the active conformation of urotensin II 162
The Outcomes of Decorated Prolines in the Discovery of Antimicrobial Peptides from Temporin-L 162
An investigation into the origin of the biased agonism associated with the urotensin II receptor activation 158
Glycine-replaced derivatives of [Pro3,DLeu9]TL, a temporin L analogue: Evaluation of antimicrobial, cytotoxic and hemolytic activities 157
Structure-Activity Relationships and Biological Characterization of a Novel, Potent, and Serum Stable C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonist 157
"3D Structural analysis of Urotensin-II analogues in membrane mimetic environment" 156
Discovery of New Potent Ligands at Human Urotensin-II Receptor 156
Monitoring the effect of antagonist on P53-MDM2 interaction with NMR spectroscopy. Recent results 150
Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors 149
Theoretical and experimental studies on the interaction of biphenyl ligands with human and murine PD-L1: Up-to-date clues for drug design 145
Disulfide bond replacement with 1,4‐ and 1,5‐disubstituted [1,2,3]‐triazole on C‐X‐C chemokine receptor type 4 (CXCR4) peptide ligands: small changes that make big differences 145
Lead Optimization of P5U and Urantide: Discovery of Novel Potent Ligands at the Urotensin-II Receptor 144
In vitro evaluation of tumor targeting ability of a parenteral enoxaparin-coated self-emulsifying drug delivery system 142
Deepening bis-(thio)carbohydrazones conformational dynamics and hydrogen bond interactions in a non-protic solvent: DFT, molecular dynamics, NMR, and Raman investigations 140
Investigation on side-product formation during the synthesis of a lactoferrin-derived lactam-bridged cyclic peptide 140
Design, Synthesis, and Cytotoxic Evaluation of AcylDerivatives of 3-Aminonaphtho[2,3-b]thiophene-4,9-dione, a Quinone-Based System 139
D-Amino Acids Containing Temporin L Analogues 137
Structure-Activity Study of the Peptides P5U and Urantide by the Development of Analogues Containing Uncoded Amino Acids at Position9 136
Breast tumor cell invasion and pro-invasive activity of cancer-associated fibroblasts co-targeted by novel urokinase-derived decapeptides 135
Visible Light-promoted C(sp3)-H α-Carbamoylation of Cyclic Ethers with Isocyanides 133
Novel α-MSH peptide analogues with broad spectrum antimicrobial activity. 133
Expanding Structure-Activity Relationships of Human Urotensin II Peptide Analogues: A Proposed Key Role of the N-Terminal Region for Novel Urotensin II Receptor Modulators 130
New insight into the binding mode of peptides at urotensin-II receptor by Trp-constrained analogues of P5U and urantide. 130
An ancestral host defence peptide within human β-defensin 3 recapitulates the antibacterial and antiviral activity of the full-length molecule 130
Synthesis and characterization of bis-triazolyl-pyridine derivatives as noncanonical DNA-interacting compounds 130
Identification of a Novel p53 Modulator Endowed with Antitumoural and Antibacterial Activity through a Scaffold Repurposing Approach 129
Design, synthesis, and conformational analysis of Melanotropin analogues of MTII and SHU9119. 129
Design, synthesis and efficacy of novel G protein-coupled receptor kinase 2 inhibitors 129
First-in-Class Cyclic Temporin L Analogue: Design, Synthesis, and Antimicrobial Assessment 129
Glioblastoma Cell Migration, Invasion and Vasculogenic Mimicry Downmodulated by Novel uPAcyclin Derivatives 128
Design, Synthesis, and Conformational Analysis of Melanotropin Analogues of MTII and SHU9119 128
NEW INSIGHT INTO THE BINDING MODE OF CYCLIC MELANOCORTIN LIGANDS AT THE MC4 RECEPTOR 128
Host Defense Peptide-derived Privileged Scaffolds for Anti-infective Drug Discovery 128
Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)-Ligand Interactions on Living Cancer Cells 127
SAR study and conformational analysis of a series of novel peptide G protein-coupled receptor kinase 2 inhibitors 124
Structure- and conformation-activity studies of nociceptin/orphanin FQ receptor dimeric ligands 123
A novel β-hairpin peptide derived from the ARC repressor selectively interacts with the major groove of B-DNA 123
Glucopeptides derived from myelin-relevant proteins and hyperglucosylated nontypeable Haemophilus influenzae bacterial adhesin cross-react with multiple sclerosis specific antibodies: A step forward in the identification of native autoantigens in multiple sclerosis 122
SOLUTION STRUCTURE OF MONOMERIC BOVINE SEMINAL RIBONUCLEASE 122
Structure and absolute stereochemistry of the new cyclolinteinol and cyclolinteinol acetate, macrophage activation modulators 122
Photomicellar Catalyzed Synthesis of Amides from Isocyanides: Optimization, Scope, and NMR Studies of Photocatalyst/Surfactant Interactions 121
Design and synthesis of the small libraries of peptidomimetics based on thiazolidine moiety 121
A proteomic approach to characterize a native antigen involved in autoantibody response in multiple sclerosis by a structure-based designed glycopeptide 121
NMR analysis of synthetic peptides agonist to PTPRJ, a receptor-type protein tyrosine phosphatase with tumor suppressor activity 121
HOPPI-NMR: Hot-Peptide-Based Screening Assay for Inhibitors of Protein-Protein Interactions by NMR 121
Structures and micelle locations of the nonlipidated and lipidated C-terminal membrane anchor of 2’,3’-cyclic nucleotide-3’-phosphodiesterase 120
Novel octreotide dicarba-analogues with high affinity and different selectivity for somatostatin receptors 120
Design, Synthesis, and Evaluation of Gluten Peptide Analogs as Selective 401 Inhibitors of Human TG2 119
Design, synthesis, and evaluation of gluten peptide analogs as selective inhibitors of human TG2 119
New Anticancer Agents Mimicking Protein Recognition Motifs. 119
Urantide Conformation and Interaction with the Urotensin-II Receptor 119
Nondenaturing polyacrylamide gel electrophoresis to study the dissociation of the p53·MDM2/X complex by potentially anticancer compounds 119
NMR analysis of synthetic peptides agonist to PTPRJ, a receptor-type protein tyrosine phosphatase with tumor suppressor activity. 118
Structure-Activity Relationship, Conformational and Biological Studies of Temporin L Analogues 118
1H and 15N sequential assignment and secondary structure of the monomeric N67D mutant of bovine seminal ribonuclease 117
Design and Synthesis of Spirotryprostatin-inspired Diketopiperazine Systemsfrom Prolyl Spirooxoindolethiazolidine Derivatives 116
Development of Cyclic Peptide Inhibitors of GRK2 115
Morphicetin analogues containing a new β-turn thiazolidine mimetic 114
Conformational study on cyclic melanocortin ligands and new insight into their binding mode at the MC4 receptor 114
Role of Lipoylation of the Immunodominant Epitope of Pyruvate Dehydrogenase Complex: Toward a Peptide-Based Diagnostic Assay for Primary Biliary Cirrhosis 114
A SARS–CoV-2 Spike Receptor Binding Motif Peptide Induces Anti-Spike Antibodies in Mice andIs Recognized by COVID-19 Patients 113
A De Novo Designed Library of Linear Helical Peptides: An Exploratory Tool in the Discovery of Protein-Protein Interaction Modulators 113
Sar Study Of P5u And Urantide Analogues Modified At Position 9 113
A novel route to synthesize Freidinger lactams by microwave irradiation 112
Identification of the Spiro(oxindole-3,3’-thiazolidine)-Based Derivatives as Potential p53 Activity Modulators 112
Structure-Activity Relationship Studies, SPR Affinity Characterization, and Conformational Analysis of Peptides That Mimic the HNK-1 Carbohydrate Epitope 112
Nuovi peptidi e peptidomimetici come agenti potenti e mirati nella prevenzione e nel trattamento dell’invasione e metastasi tumorali 111
Development of Antiviral Fusion Inhibitors: Short Modified Peptides Derived from the Transmembrane Glycoprotein of Feline Immunodeficiency Virus 111
Synthesis and pharmacological evaluation of some 4-oxo-quinoline-2-carboxylic acid derivatives as anti-inflammatory and analgesic agents 111
Stereostructures of new bioactive sesterterpenes isolated from the Caribbean sponge Cacospongia cf. linteiformis 111
3D structure of monomeric bovine seminal ribonuclease by heteronuclear NMR 110
Conformational Properties of a Peptide-Bridge between Tubulin and Plasma Membrane 109
Synthetic short-chain peptide analogues of H1 relaxin lack affinity for the RXFP1 receptor and relaxin-like bioactivity. Clues to a better understanding of relaxin agonist design 108
Introduction of constrained Trp analogs in RW9 modulates structure and partition in membrane models 107
SAR Study and Conformational Analysis of a Series of Novel GRK2 Peptide inhibitors 107
Solution structure of monomeric bovine seminal ribonuclease 106
Combinatorial Approach in the Synthesis of a Small Library of β-Turn Structures Based on Thiazolidine Moiety 105
Unraveling the active conformation of urotensin II 105
UROTENSIN-II PEPTIDE AGONISTS AND ANTAGONISTS: A COMPREHENSIVE SAR STUDY 103
Novel cyclic biphalin analogue with improved antinociceptive properties. 103
STRUCTURAL STUDIES OF GLUTEN - PEPTIDE ANALOGS 102
Synthesis, in vitro, and in cell studies of a new series of [Indoline-3,2'-thiazolidine]-based p53 modulators. 101
SAR Study on CN17β a Potent and Selective CaMKII Peptide Inhibitor 101
Synthesis of a Dicarba-Analog of Octreotide Keeping the Type II Beta-Turn of the Pharmacophore in Water Solution 100
Spiro[(dihydropyrazin-2,5-dione)-6,3’-(2’,3’-dihydrothieno[2,3-b]naphtho-4’,9’-dione)]-Based Cytotoxic Agents: Structure-Activity Relationship Studies on the Substituent at N4-Position of the Diketopiperazine Domain 100
UT RECEPTOR LIGANDS. SWITCHING FROM AGONIST TO ANTAGONIST ACTIVITY 100
Microwave-Assisted Solid Phase Synthesis of Backbone Cyclic Glycopeptide Libraries 98
Porrigenins A and B, novel cytotoxic and antiproliferative sapogenins isolated from Allium porrum 97
A New, Potent Urotensin II Receptor Peptide Agonist Containing a Pen Residue at the Disulfide Bridge 96
Design, Synthesis, Conformational Analysis, and Biological Studies of Urotensin II Lactam analogues 96
Totale 12.967
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.679
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.679
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.003 0 0 12 26 19 22 16 27 234 81 121 445
2022/20231.359 198 102 54 127 153 149 9 121 192 169 62 23
2023/2024989 55 139 171 56 64 93 15 127 13 16 174 66
2024/20255.248 254 307 56 73 83 314 508 328 472 573 1.814 466
2025/20269.586 1.106 751 1.053 921 1.505 395 1.175 517 1.115 619 248 181
2026/2027548 181 348 19 0 0 0 0 0 0 0 0 0
Totale 20.778